Product Information
HYDROCHLOROTHIAZIDE 50 MG TAB is a generic product labeled by Solco Healthcare US LLC, priced at $0.0316 per EA under NDC 43547039810. Its NADAC has been published 488 times since May 31, 2017.
FDA first approved this application on Mar 29, 2002.
Strength
50 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547039810
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040412FDA Approved
3/29/2002
On Market Since
3/29/2002
Pharmacological Classes
Price Statistics
The NADAC for HYDROCHLOROTHIAZIDE 50 MG TAB has been published 488 times since May 31, 2017, and over the history we have for it it has risen 3.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0316 per EA |
|---|---|
| All-time high | $0.0394 (Jun 14, 2023) |
| All-time low | $0.0208 (Oct 17, 2018) |
| 52-week high | $0.0346 |
| 52-week low | $0.0310 |
| Median price | $0.0312 |
| Average price | $0.0304 |
| Largest weekly change | +29.7% (Aug 21, 2024) |
| Weeks tracked | 488 |
| Tracking since | May 31, 2017 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Solco Healthcare US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrochlorothiazide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Thiazide Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCHLOROTHIAZIDE 50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCHLOROTHIAZIDE 50 MG TAB, manufactured by Solco Healthcare US LLC, is $0.0316 per EA (NDC 43547039810), effective Sep 30, 2026.
How has the price of HYDROCHLOROTHIAZIDE 50 MG TAB changed over time?
Over the history we have for it, the NADAC for HYDROCHLOROTHIAZIDE 50 MG TAB has risen 3.4%. It has been tracked across 488 weekly CMS publications since May 31, 2017.
What are the highest and lowest recorded NADAC prices for HYDROCHLOROTHIAZIDE 50 MG TAB?
Since May 31, 2017, the NADAC for HYDROCHLOROTHIAZIDE 50 MG TAB has ranged from a low of $0.0208 (Oct 17, 2018) to a high of $0.0394 (Jun 14, 2023), with a median of $0.0312 per EA.
Are there cheaper alternatives to HYDROCHLOROTHIAZIDE 50 MG TAB?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDROCHLOROTHIAZIDE 50 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDROCHLOROTHIAZIDE 50 MG TAB?
HYDROCHLOROTHIAZIDE 50 MG TAB (NDC 43547039810) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.